Truist Securities reiterates Tesla stock Hold rating at $400 target By Investing.com

The key market issue is not the earnings beat; it is the implied rerating of Tesla from a cyclical auto manufacturer to a capital-intensive option on AI and autonomy. Higher capex pushes reported free cash flow toward zero or negative in the near term, which removes the main valuation support for investors who were underwriting TSLA as a cash compounder. That makes the stock more duration-sensitive: if the market’s discount rate stays high, the multiple can compress even if operational execution remains solid.

Second-order effects matter more than the headline spend. Incremental capex into autonomy, compute, and robotics likely deepens Tesla’s dependence on external semiconductor, foundry, networking, and power infrastructure vendors, while reducing relevance of delivery cadence and other auto KPIs. That shifts the competitive battleground toward companies that can monetize picks-and-shovels exposure to AI buildout without the execution risk of a consumer hardware platform. It also raises the bar for rivals in EVs, because Tesla can use the balance sheet and brand to subsidize a longer commercialization window.

The consensus is probably underestimating how much of the near-term upside is already in the stock. When a company trades on optionality, capex acceleration is only bullish if the market believes the payoff window is within 12-24 months; otherwise it reads as a cash burn increase. The catalyst path is binary: progress on robotaxi/autonomy milestones or meaningful inference/robotics revenue can re-rate the stock, but any delay in monetization makes the current valuation vulnerable to a 10-20% drawdown as investors refocus on negative FCF and lack of guidance.